Home > Drug Search >
  • company_query: Bracco
  •   > 
Drug Filter
Category:
chemistry (31) biology (14)
Status:
Approved (9) Phase Ⅲ (5) Phase Ⅱ (19) Phase Ⅰ (12)
Clinical Stage:
Pending (5) Active (17) Discontinued (14)
Bio-Type:
Gene therapy (1) Cell therapy (1) Vaccine (5) Recombinant cytokines (1) Whole antibody (2)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (4) Alzheimer's disease (AD) (1) Anaesthetic (1) Bladder cancer (1) Cancer chemotherapy (1) Cancer related pain (1) Oedema (1) Chronic lymphocytic leukemia (CLL) (1) ischaemic heart disorder (1) Contrast agents (4) Crohn's disease (1) Follicular lymphoma (1) HCV infection (1) Heart failure (1) Hepatocellular carcinoma (HCC) (1) HIV infection (3) Hypertension (1) Leukemia (1) Malignancies (1) Melanoma (3) Moderate-to-severe acute pain (1) Multiple myeloma (MM) (2) Multiple sclerosis (MS) (2) Myelodysplastic syndrome (MDS) (2) Neuropathic pain (3) Non small cell lung cancer (NSCLC) (2) Non-Hodgkin B-cell lymphomas (1) Ovarian cancer (1) Pancreatic cancer (4) Postoperative pain (1) Prostate cancer (3) Rheumatoid arthritis (RA) (1) Sedation (2) Solid tumours (4) Thyroid cancer (1) Reperfusion injury (1) Colorectal cancer (2) Dermatitis (1) Skin pruritus (1) Hypokalaemia (1) Pain (2) Stroke (4) Cholecystitis (1) Renal carcinoma (1) Brain injury (1) Glioblastoma (2) Glioma (1) Diffuse large B cell lymphoma (1) Celiac disease (1) Neurological disease (1) hematological malignancies (1)
Country:
Aprv. Year:
2004 (1) 2009 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top